eFFECTOR Therapeutics Net Tangible Assets

eFFECTOR Therapeutics (EFTR) currently reports a net tangible assets of $220M as of March 2026. That compares with $-22K in the prior-year period — up 969571.7% year over year. Use the charts on this page to explore eFFECTOR Therapeutics's net tangible assets history and peer comparisons.

eFFECTOR Therapeutics's net tangible assets increased from $-22K to $220M — a 969571.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

eFFECTOR Therapeutics reported $220M in net tangible assets as of March 2026. That compares with $-22K in the prior-year period — up 969571.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for eFFECTOR Therapeutics, and consider following EFTR for alerts when major investors trade the stock.

eFFECTOR Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EFTR with unrelated industries.